+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Specialty PACS Market Size, Share & Industry Trends Analysis Report By Deployment Model, By Type, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), By Regional Outlook and Forecast, 2021-2027

  • ID: 5570993
  • Report
  • February 2022
  • Region: Global
  • 226 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Canon, Inc.
  • Carestream Health, Inc.
  • Escalon Medical Corp.
  • IBM Corporation
  • Koninklijke Philips N.V.
  • McKesson Corporation
The Global Specialty PACS Market size is expected to reach $3.6 billion by 2027, rising at a market growth of 4.9% CAGR during the forecast period.

The enhancements in biomedical technologies have improved the way of doctors analyze patients’ data. The PACS systems are one of such technological advancements. PACS refers to picture archiving & communication skill systems, which is an imaging technology mainly used by the healthcare industry.

The PACS helps in the transmission of the image from the site of acquisition to multiple locations that require the image. The picture archiving & communication system is capable to access multiple models like CT, radiographs, ultrasound, and MRI at the same time on multiple locations within the hospitals as well as across different areas.

The main function of PACS is to make image viewing easier and help to manage the medical data.  For example, to match the requirements of technology in the healthcare sector, the JPI healthcare solutions designed ExamVue PACS. The ExamVue PACS can be used by large as well as small hospitals with a limit of 10 viewers. This software can easily be installed across the office to show the x rays of patients as well as to perform diagnoses in the private office.

The World Health Organization predicts that the population of people with the age of 60 or more will increase up to 2 billion by 2050 in the world, which is expected to result in the demand for healthcare services. Moreover, the increasing investment in medical imaging will boost the demand for specialty PACS. The major factor responsible for the increased load on healthcare sector is the rising number of scans among various small & large medical facilities.



COVID-19 Impact Analysis


The outbreak of the COVID-19 pandemic has impacted almost all the industries across the world. The pandemic has brutally affected the specialty PACS market which has recorded a decrease in the demand for PACS devices.

In addition, the disturbance in import & export of raw material as well as final products, less production due to the complete lockdown along with various other restrictions imposed by the government authorities resulted in disrupted supply chain. Also, the increased number of healthcare workers falling ill in the pandemic has led to the less productivity. The decline in hospital visits due to the risk of coronavirus spread has resulted in reduced demand for PACS systems in the market.

Market Growth Factors:


Increasing geriatric population


The number of aged population is continuously rising in the world. Various problems are accompanied by the aging of the musculoskeletal system which results in changes in bones and soft tissues. The risk of fractures due to alteration in bone-like osteoporosis & osteomalacia is more in old age people. Osteoarthritis is one of the common musculoskeletal diseases found in the elder population. Thus, the surgeries in old age people is also high due to high spread of chronic diseases.

Advantages associated with specialty PACS


The adoption of picture archiving & communication systems (PACS) has changed the working style of the healthcare industry. The technological advancements have made it possible for physicians to share medical images report electronically with ease and in less time with the help of PACS systems. The main advantage of PACS systems is that it provides digital imaging which enables medical professionals to have a closer and clear look at images.

Marketing Restraining Factor:


Inefficiency of PACS systems


Instead of various benefits associated with the use of PACS systems for imaging, the PACS system can also be a confusing decision for the radiology providers and outpatient imaging centers. Each center deals with the different situations and thus requires different specialized solution. The PACS systems mainly focus on the needs of radiology facilities of healthcare centers, whereas the administrators of imaging centers do not have the same requirements as hospital administrators which sometime make the PACS system inefficient for such imaging centers.



Deployment Model Outlook


Based on the deployment model, the specialty PACS market is fragmented into on-premises specialty PACS, cloud-based specialty PACS. In 2020, the on-premises specialty PACS segment dominated the specialty PACS market by generating the highest revenue share. This dominance is because of the spread of various chronic diseases in both developing & developed countries, growing demand for medical imaging, and various initiatives taken by the government.

Type Outlook


On the basis of type, the specialty PACS market is segmented into radiology PACS, orthopedics PACS, oncology PACS, pathology PACS, ophthalmology PACS, women’s health PACS. The orthopedics PACS segment acquired a significant revenue share in the specialty PACS market in 2020. Increasing demand for making image integration flexible which lets the surgeons easily access images from anywhere has grown the adoption of specialty PACS systems in orthopedics.

End User Outlook


By end user, the specialty PACS market is categorized into hospitals & clinics and ambulatory surgical centers. In 2020, the ambulatory surgical centers segment accounted for a significant revenue share in the specialty PACS market. These are the modern healthcare facilities providing same day diagnoses because of the lesser stay time of patient they require to have a fast and efficient technology for imaging which is increasing the demand for of PACS systems in this segment.

Regional Outlook


Region wise, the specialty PACS market is analyzed in North America, Europe, Asia Pacific, and LAMEA. In 2020, the North America region emerged as the leading region in the specialty PACS market with the largest revenue share. This is because of the rise in the availability of better health care facilities & skilled medical professionals along with the increasing investment by the government in the healthcare industry in the region.

Cardinal Matrix - Specialty PACS Market Competition Analysis




The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; International Business Machines Corporation and Siemens AG are the forerunners in the Specialty PACS Market. Companies such as Canon, Inc., INFINITT Healthcare Co. Ltd. and Topcon Corporation are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novarad Enterprise Healthcare Solutions, Escalon Medical Corp., IBM Corporation, Siemens AG, Canon, Inc., INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., McKesson Corporation, Carestream Health, Inc., and Topcon Corporation.

Recent Strategy Deployed in Specialty PACS Market


Partnerships, Collaborations and Agreements:

  • Jan-2022: Infinitt partnered with Lunit, a medical AI software company. The company aimed to provide Lunit AI software that efficiently analyzes mammography images to detect lesions capable of indicating breast cancer & providing location information for any detected lesions in the form of outlines & heatmaps.
  • Nov-2021: Novarad extended its partnership with PenRad, a provider of automated tracking and reporting system for lung screening. The partnership aimed to integrate PenRad 's lung screening platform, PenLung with NovaPACS enterprise imaging platform.
  • Aug-2021: Topcon Healthcare entered into a partnership with RetInSight, a developer of retina AI solutions based in Vienna, Austria. This partnership aimed to design a seamless interface between RetInSight’s AI-assisted retinal biomarker applications & Topcon’s market-leading¹ OCT devices & cloud-based data management solution, Harmony.
  • Nov-2020: Siemens Healthineers came into a partnership with the University of Iowa Health Care (UI Healthcare), a comprehensive academic medical center providing world-class health care & health-related outreach services to all Iowan. The partnership aimed to provide Iowans with access to cutting-edge medical imaging technology as well as leverage AI and data analytics to enhance the performance & efficiency of medical imaging which is expected to expand research opportunities and invest in training & development for staff & students.
  • Sep-2020: Siemens join hands with WakeMed Health & Hospitals, a 919-bed healthcare system with multiple facilities placed around the metropolitan Raleigh, North Carolina area. Under this partnership, the companies is expected to innovate care delivery and enhance patient outcomes by advanced imaging capabilities, robotics initiatives, & artificial intelligence along with provider and staff training.
  • Aug-2020: Canon Medical entered into a partnership with Zebra Medical Vision, a pioneer in the AI medical imaging space setting the standard for advanced AI in radiology. Through this partnership, the companies is expected to offer AI1 automated imaging analysis solutions for providing clinicians with fast and accurate diagnoses for optimized patient care.

Product Launches and Product Expansions:

  • Nov-2021: IBM Watson Health launched IBM Imaging AI Orchestrator, a cloud-based subscription to multiple imaging AI apps. Through this launch, the company aimed to help imaging organizations mainly radiologists experience the benefits of having AI applications work seamlessly together. In addition, this latest solution is expected to modernize the radiologist's reading experience as well as reduce the need for IT and imaging system administrators.
  • Aug-2021: Canon Medical Expanded AI-Based Image Reconstruction Technology to Body Applications on Galan 3T MR System. The expansion is expected to demonstrate the company's commitment to offering accessible AI which can be used by clinicians to make the greatest impact on patient care by making images easy to analyze and access.
  • Jun-2021: Novarad Corporation unveiled CryptoChart, a software-only version of its award-winning medical information sharing product. The CryptoChart is expected to allow physicians to share medical images and medical chart information safely, securely, and instantly through a QR code instead of burning a CD or creating complex user names and passwords.

Approvals and Trials:

  • Jul-2021: Topcon Corporation took over VISIA Imaging, an ophthalmic device manufacturer headquartered in Florence, Italy. This acquisition aimed to improve the company’s development & manufacturing capabilities of anterior segment devices & software, which enhance the company’s strong portfolio of posterior segment imaging devices which include fundus cameras & optical coherence tomography (OCT). In addition, the acquisition is expected to also reinforce Topcon’s position as a leading ophthalmic diagnostic device manufacturer.

Scope of the Study


Market Segments Covered in the Report:


By Deployment Model
  • On premises
  • Cloud-based

By Type
  • Radiology PACS
  • Orthopedics PACS
  • Oncology PACS
  • Pathology PACS
  • Ophthalmology PACS
  • Women’s health PACS
  • Others

By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Novarad Enterprise Healthcare Solutions
  • Escalon Medical Corp.
  • IBM Corporation
  • Siemens AG
  • Canon, Inc.
  • INFINITT Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Carestream Health, Inc.
  • Topcon Corporation

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Canon, Inc.
  • Carestream Health, Inc.
  • Escalon Medical Corp.
  • IBM Corporation
  • Koninklijke Philips N.V.
  • McKesson Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Specialty PACS Market, by Deployment Model
1.4.2 Global Specialty PACS Market, by Type
1.4.3 Global Specialty PACS Market, by End User
1.4.4 Global Specialty PACS Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnership, Collaborations and Agreements: 2017, Jul – 2022, Jan) Leading Players
Chapter 4. Global Specialty PACS Market by Deployment Model
4.1 Global On premises Market by Region
4.2 Global Cloud-based Market by Region
Chapter 5. Global Specialty PACS Market by Type
5.1 Global Radiology PACS Market by Region
5.2 Global Orthopedics PACS Market by Region
5.3 Global Oncology PACS Market by Region
5.4 Global Pathology PACS Market by Region
5.5 Global Ophthalmology PACS Market by Region
5.6 Global Women’s health PACS Market by Region
5.7 Global Other Type Market by Region
Chapter 6. Global Specialty PACS Market by End User
6.1 Global Hospitals & Clinics Market by Region
6.2 Global Ambulatory Surgical Centers Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Specialty PACS Market by Region
7.1 North America Specialty PACS Market
7.1.1 North America Specialty PACS Market by Deployment Model
7.1.1.1 North America On premises Market by Country
7.1.1.2 North America Cloud-based Market by Country
7.1.2 North America Specialty PACS Market by Type
7.1.2.1 North America Radiology PACS Market by Country
7.1.2.2 North America Orthopedics PACS Market by Country
7.1.2.3 North America Oncology PACS Market by Country
7.1.2.4 North America Pathology PACS Market by Country
7.1.2.5 North America Ophthalmology PACS Market by Country
7.1.2.6 North America Women’s health PACS Market by Country
7.1.2.7 North America Other Type Market by Country
7.1.3 North America Specialty PACS Market by End User
7.1.3.1 North America Hospitals & Clinics Market by Country
7.1.3.2 North America Ambulatory Surgical Centers Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Specialty PACS Market by Country
7.1.4.1 US Specialty PACS Market
7.1.4.1.1 US Specialty PACS Market by Deployment Model
7.1.4.1.2 US Specialty PACS Market by Type
7.1.4.1.3 US Specialty PACS Market by End User
7.1.4.2 Canada Specialty PACS Market
7.1.4.2.1 Canada Specialty PACS Market by Deployment Model
7.1.4.2.2 Canada Specialty PACS Market by Type
7.1.4.2.3 Canada Specialty PACS Market by End User
7.1.4.3 Mexico Specialty PACS Market
7.1.4.3.1 Mexico Specialty PACS Market by Deployment Model
7.1.4.3.2 Mexico Specialty PACS Market by Type
7.1.4.3.3 Mexico Specialty PACS Market by End User
7.1.4.4 Rest of North America Specialty PACS Market
7.1.4.4.1 Rest of North America Specialty PACS Market by Deployment Model
7.1.4.4.2 Rest of North America Specialty PACS Market by Type
7.1.4.4.3 Rest of North America Specialty PACS Market by End User
7.2 Europe Specialty PACS Market
7.2.1 Europe Specialty PACS Market by Deployment Model
7.2.1.1 Europe On premises Market by Country
7.2.1.2 Europe Cloud-based Market by Country
7.2.2 Europe Specialty PACS Market by Type
7.2.2.1 Europe Radiology PACS Market by Country
7.2.2.2 Europe Orthopedics PACS Market by Country
7.2.2.3 Europe Oncology PACS Market by Country
7.2.2.4 Europe Pathology PACS Market by Country
7.2.2.5 Europe Ophthalmology PACS Market by Country
7.2.2.6 Europe Women’s health PACS Market by Country
7.2.2.7 Europe Other Type Market by Country
7.2.3 Europe Specialty PACS Market by End User
7.2.3.1 Europe Hospitals & Clinics Market by Country
7.2.3.2 Europe Ambulatory Surgical Centers Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Specialty PACS Market by Country
7.2.4.1 Germany Specialty PACS Market
7.2.4.1.1 Germany Specialty PACS Market by Deployment Model
7.2.4.1.2 Germany Specialty PACS Market by Type
7.2.4.1.3 Germany Specialty PACS Market by End User
7.2.4.2 UK Specialty PACS Market
7.2.4.2.1 UK Specialty PACS Market by Deployment Model
7.2.4.2.2 UK Specialty PACS Market by Type
7.2.4.2.3 UK Specialty PACS Market by End User
7.2.4.3 France Specialty PACS Market
7.2.4.3.1 France Specialty PACS Market by Deployment Model
7.2.4.3.2 France Specialty PACS Market by Type
7.2.4.3.3 France Specialty PACS Market by End User
7.2.4.4 Russia Specialty PACS Market
7.2.4.4.1 Russia Specialty PACS Market by Deployment Model
7.2.4.4.2 Russia Specialty PACS Market by Type
7.2.4.4.3 Russia Specialty PACS Market by End User
7.2.4.5 Spain Specialty PACS Market
7.2.4.5.1 Spain Specialty PACS Market by Deployment Model
7.2.4.5.2 Spain Specialty PACS Market by Type
7.2.4.5.3 Spain Specialty PACS Market by End User
7.2.4.6 Italy Specialty PACS Market
7.2.4.6.1 Italy Specialty PACS Market by Deployment Model
7.2.4.6.2 Italy Specialty PACS Market by Type
7.2.4.6.3 Italy Specialty PACS Market by End User
7.2.4.7 Rest of Europe Specialty PACS Market
7.2.4.7.1 Rest of Europe Specialty PACS Market by Deployment Model
7.2.4.7.2 Rest of Europe Specialty PACS Market by Type
7.2.4.7.3 Rest of Europe Specialty PACS Market by End User
7.3 Asia Pacific Specialty PACS Market
7.3.1 Asia Pacific Specialty PACS Market by Deployment Model
7.3.1.1 Asia Pacific On premises Market by Country
7.3.1.2 Asia Pacific Cloud-based Market by Country
7.3.2 Asia Pacific Specialty PACS Market by Type
7.3.2.1 Asia Pacific Radiology PACS Market by Country
7.3.2.2 Asia Pacific Orthopedics PACS Market by Country
7.3.2.3 Asia Pacific Oncology PACS Market by Country
7.3.2.4 Asia Pacific Pathology PACS Market by Country
7.3.2.5 Asia Pacific Ophthalmology PACS Market by Country
7.3.2.6 Asia Pacific Women’s health PACS Market by Country
7.3.2.7 Asia Pacific Other Type Market by Country
7.3.3 Asia Pacific Specialty PACS Market by End User
7.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
7.3.3.2 Asia Pacific Ambulatory Surgical Centers Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Specialty PACS Market by Country
7.3.4.1 China Specialty PACS Market
7.3.4.1.1 China Specialty PACS Market by Deployment Model
7.3.4.1.2 China Specialty PACS Market by Type
7.3.4.1.3 China Specialty PACS Market by End User
7.3.4.2 Japan Specialty PACS Market
7.3.4.2.1 Japan Specialty PACS Market by Deployment Model
7.3.4.2.2 Japan Specialty PACS Market by Type
7.3.4.2.3 Japan Specialty PACS Market by End User
7.3.4.3 India Specialty PACS Market
7.3.4.3.1 India Specialty PACS Market by Deployment Model
7.3.4.3.2 India Specialty PACS Market by Type
7.3.4.3.3 India Specialty PACS Market by End User
7.3.4.4 South Korea Specialty PACS Market
7.3.4.4.1 South Korea Specialty PACS Market by Deployment Model
7.3.4.4.2 South Korea Specialty PACS Market by Type
7.3.4.4.3 South Korea Specialty PACS Market by End User
7.3.4.5 Singapore Specialty PACS Market
7.3.4.5.1 Singapore Specialty PACS Market by Deployment Model
7.3.4.5.2 Singapore Specialty PACS Market by Type
7.3.4.5.3 Singapore Specialty PACS Market by End User
7.3.4.6 Malaysia Specialty PACS Market
7.3.4.6.1 Malaysia Specialty PACS Market by Deployment Model
7.3.4.6.2 Malaysia Specialty PACS Market by Type
7.3.4.6.3 Malaysia Specialty PACS Market by End User
7.3.4.7 Rest of Asia Pacific Specialty PACS Market
7.3.4.7.1 Rest of Asia Pacific Specialty PACS Market by Deployment Model
7.3.4.7.2 Rest of Asia Pacific Specialty PACS Market by Type
7.3.4.7.3 Rest of Asia Pacific Specialty PACS Market by End User
7.4 LAMEA Specialty PACS Market
7.4.1 LAMEA Specialty PACS Market by Deployment Model
7.4.1.1 LAMEA On premises Market by Country
7.4.1.2 LAMEA Cloud-based Market by Country
7.4.2 LAMEA Specialty PACS Market by Type
7.4.2.1 LAMEA Radiology PACS Market by Country
7.4.2.2 LAMEA Orthopedics PACS Market by Country
7.4.2.3 LAMEA Oncology PACS Market by Country
7.4.2.4 LAMEA Pathology PACS Market by Country
7.4.2.5 LAMEA Ophthalmology PACS Market by Country
7.4.2.6 LAMEA Women’s health PACS Market by Country
7.4.2.7 LAMEA Other Type Market by Country
7.4.3 LAMEA Specialty PACS Market by End User
7.4.3.1 LAMEA Hospitals & Clinics Market by Country
7.4.3.2 LAMEA Ambulatory Surgical Centers Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Specialty PACS Market by Country
7.4.4.1 Brazil Specialty PACS Market
7.4.4.1.1 Brazil Specialty PACS Market by Deployment Model
7.4.4.1.2 Brazil Specialty PACS Market by Type
7.4.4.1.3 Brazil Specialty PACS Market by End User
7.4.4.2 Argentina Specialty PACS Market
7.4.4.2.1 Argentina Specialty PACS Market by Deployment Model
7.4.4.2.2 Argentina Specialty PACS Market by Type
7.4.4.2.3 Argentina Specialty PACS Market by End User
7.4.4.3 UAE Specialty PACS Market
7.4.4.3.1 UAE Specialty PACS Market by Deployment Model
7.4.4.3.2 UAE Specialty PACS Market by Type
7.4.4.3.3 UAE Specialty PACS Market by End User
7.4.4.4 Saudi Arabia Specialty PACS Market
7.4.4.4.1 Saudi Arabia Specialty PACS Market by Deployment Model
7.4.4.4.2 Saudi Arabia Specialty PACS Market by Type
7.4.4.4.3 Saudi Arabia Specialty PACS Market by End User
7.4.4.5 South Africa Specialty PACS Market
7.4.4.5.1 South Africa Specialty PACS Market by Deployment Model
7.4.4.5.2 South Africa Specialty PACS Market by Type
7.4.4.5.3 South Africa Specialty PACS Market by End User
7.4.4.6 Nigeria Specialty PACS Market
7.4.4.6.1 Nigeria Specialty PACS Market by Deployment Model
7.4.4.6.2 Nigeria Specialty PACS Market by Type
7.4.4.6.3 Nigeria Specialty PACS Market by End User
7.4.4.7 Rest of LAMEA Specialty PACS Market
7.4.4.7.1 Rest of LAMEA Specialty PACS Market by Deployment Model
7.4.4.7.2 Rest of LAMEA Specialty PACS Market by Type
7.4.4.7.3 Rest of LAMEA Specialty PACS Market by End User
Chapter 8. Company Profiles
8.1 Novarad Enterprise Healthcare Solutions
8.1.1 Company Overview
8.1.2 Recent Strategies and developments:
8.1.2.1 Partnerships, Collaborations and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.2 Escalon Medical Corp.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent Strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Siemens AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent Strategies and developments:
8.4.5.1 Partnerships, Collaborations and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisitions and Mergers:
8.4.6 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and developments:
8.5.5.1 Partnerships, Collaborations and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 INFINITT Healthcare Co. Ltd.
8.6.1 Company Overview
8.6.2 Recent Strategies and developments:
8.6.2.1 Partnerships, Collaborations and Agreements:
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisitions and Mergers:
8.8 McKesson Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Carestream Health, Inc. (Onex Corporation)
8.9.1 Company Overview
8.10. Topcon Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Recent Strategies and developments:
8.10.4.1 Partnerships, Collaborations and Agreements:
8.10.4.2 Acquisitions and Mergers:
Note: Product cover images may vary from those shown
  • Novarad Enterprise Healthcare Solutions
  • Escalon Medical Corp.
  • IBM Corporation
  • Siemens AG
  • Canon, Inc.
  • INFINITT Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Carestream Health, Inc.
  • Topcon Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...